Federal Register MedWatch Pharma News Warning Letters
LEVOCABASTINE HYDROCHLORIDE Suspension/Drops; Ophthalmic 0.05% BASE LIVOSTIN NOVARTIS
For the most up-to-date approval information, please locate this API using the drug index.